To view an archived recording of this presentation please click the following link:
|
|
- Barrie Briggs
- 5 years ago
- Views:
Transcription
1 To view an archived recording of this presentation please click the following link: Please scroll down this file to view a copy of the slides from the session.
2 Helpful tips when viewing the recording: The default presentation format includes showing the event index. To close the events index, please click on the following icon and hit close If you prefer to view the presentation in full screen mode, please click on the following icon in the top right hand corner of the share screen PublicHealthOntario.ca
3 What s new with the flu - The Universal Influenza Vaccination Program and influenza vaccines for the influenza season Overview and update September 22, 2015
4 Outline Overview of the Universal Influenza Immunization Program (UIIP) Stacy Recalla, Nurse Consultant, Ministry of Health and Long Term Care Vaccines Included in the UIIP recommended uses and indications Bryna Warshawsky, Public Health Physician, Public Health Ontario Questions and Answers PublicHealthOntario.ca 4
5 Part 1: Overview of Ontario s UIIP Context and Background re: Ontario s UIIP History Program Objectives Program Delivery Ontario s 2015/16 UIIP Coordinated planning for the 2015/16 influenza season 2015/16 publicly funded influenza vaccines Next Steps re: implementation 5
6 Ontario s UIIP: Context and Overview Ontario was the first jurisdiction in North America to implement the Universal Influenza Immunization Program (UIIP), which offers influenza vaccine free of charge each year to all persons six months of age and older who live, work or go to school in Ontario. 6
7 Objectives of the UIIP Launched in the fall of 2000 as part of the commitment to protect and promote the health of Ontarians, the UIIP aims to: Provide individual protection against influenza; Reduce the number and severity of influenza cases; Reduce the impact on the health care system during the influenza season; and Decrease the overall economic impact in both direct health care costs and indirect societal costs. 7
8 UIIP Program Delivery Key Components Annual application process for pharmacies and health care agencies Two-step process requiring a ministry-approved application and a public health unitapproved cold chain inspection Dissemination of UIIP Implementation Package Each year, the Ministry distributes UIIP implementation packages for all participating providers, which includes information on: Recommended influenza vaccine recipients Influenza vaccine supply Eligibility for specific influenza vaccines Information on vaccine ordering, including Vaccine Order Forms Information on reporting vaccine administration Distribution of Flu Vaccine The ministry usually begins distributing influenza vaccine to public health units (PHUs) in mid-late September. Providers generally start receiving vaccine about a week later, with high risk groups being the first priority for immunization. 8
9 UIIP Program Delivery (continued) Important role of public health units PHUs are instrumental in managing the UIIP at the local level, including conducting annual cold chain inspections, vaccine distribution to local providers, as well as conducting their own influenza immunization clinics. Flu vaccine clinics / settings Influenza vaccine is available through primary care providers, public health unit clinics, pharmacies, and in various other settings such as long-term care homes, workplaces, hospitals and community health centres. Communications The Ministry s Communications and Marketing Division (CMD) supports the UIIP rollout each year with a comprehensive communications plan. In addition, the ministry hosts an application during flu season where Ontarians can visit and use the Flu Vaccine Locator Tool to find an influenza immunization clinic nearby. 9
10 UIIP Program Delivery - Pharmacies In 2012, the scope of practice for pharmacists was expanded to include administration of the influenza vaccine to Ontarians 5 years of age and older in accordance with the UIIP. Each year since this initiative began, the number of doses of publicly funded influenza vaccine administered by trained pharmacists has increased as follows: In 2012/13, approximately 250,000 doses were administered through approximately 620 participating pharmacies. In 2013/14, approximately 766,000 doses were administered through approximately 2000 participating pharmacies. In 2014/15, approximately 901,000 doses were administered through approximately 2400 participating pharmacies. Building on these successes, the ministry anticipates that this initiative will continue to increase Ontarians access to influenza vaccine with approximately 2,500 pharmacies participating this year. 10
11 Ontario s 2015/16 UIIP: Coordinated Planning Influenza planning at the provincial level involves a number of parties: Ministry of Health and Long-Term Care: Public Health Policy and Programs Branch (of Public Health Division) provincial management and oversight of UIIP; health care worker influenza immunization Emergency Management Branch (of Public Health Division) - monitoring of influenza activity and planning for health system impacts and contingencies related to influenza Communications and Marketing Division influenza-related communications campaigns and material Public Health Ontario: scientific and technical support related to all influenza program activities; influenza surveillance and vaccine effectiveness analysis; publishing respiratory pathogen surveillance reports. To ensure a coordinated approach, a provincial influenza planning group chaired by PHD meets bi-weekly, with representation from all of the above areas. 11
12 2015/16 Publicly Funded Flu Vaccines (TIV) Vaccine Formulation Agriflu / Fluviral Influvac Fluad Trivalent inactivated vaccine (TIV) Trivalent inactivated vaccine (TIV) Trivalent inactivated vaccine (adjuvanted) (TIV-adjuvanted) Dosage 0.5mL 0.5mL 0.5mL Route of Administration Intramuscular Injection Intramuscular Injection Intramuscular Injection Eligibility 6 months and older* 18 years and older 65 years and older who reside in LTCH Potential Allergens Agriflu: Fluviral: Egg protein^ Egg protein^ Kanamycin Thimerosal Neomycin Thimerosal Egg protein^ Chicken protein Gentamicin Egg protein^ Chicken protein Kanamycin Neomycin Package Description Multi-dose vial Single dose syringe Single dose syringe Once punctured, discard vial after Package Dimensions L x W x H 28 days n/a n/a 3cm x 3cm x 7cm 18.8cm x 15.2cm x 1.7cm 10.8cm x 10.2cm x 4.4cm 12
13 2015/16 Publicly Funded Flu Vaccines (QIV) Vaccine Formulation Dosage Route of Administration Eligibility FluLaval Tetra / Fluzone Quadrivalent Quadrivalent inactivated vaccine (QIV) 0.5mL Intramuscular Injection 6 months through 17 years Potential Allergens FluLaval: Fluzone: Egg protein^ Thimerosal Egg protein ^ Thimerosal Package Description Once punctured, discard vial after Package Dimensions LxWxH Multi-dose vial FluLaval: Fluzone: 28 days expiry date indicated on vial 3cm x 3cm x 6cm 13
14 Influenza Vaccines for Specific Age Groups: Age Group 6 months through 17 years Recommended Vaccine QIV Alternative Vaccine TIV (if requested or if QIV is not available) 18 years and older TIV None 65 years and older who reside in LTCH TIV-adjuvanted TIV (if requested or if TIVadjuvanted is not available) Only Agriflu and Fluviral can be used to immunize individuals less than 18 years of age. 14
15 2015/16 UIIP: Next Steps Flu Vaccine Supply and Distribution Distribution of influenza vaccine is always intermittent, as each province and territory receives their influenza vaccine supply over a number of shipments. The Ministry anticipates that the first shipments of flu vaccine will be distributed from the provincial warehouse to public health units next week, for further distribution to local providers. UIIP Implementation Package The expected timing for release of these packages for the 2015/16 season is early October. 15
16 Acknowledgements Members of the UIIP Coordinated Planning Group: Dianne Alexander, MOHLTC Thomas Appleyard, MOHLTC Lucia De Stefano, MOHLTC Melissa Helferty, MOHLTC Amir Kahnamouee, MOHLTC Emily Karas, PHO Sarah Levitt, MOHLTC Tsui Scott, MOHLTC Brixhilda Shedollari, MOHLTC Dr. Bryna Warshawsky, PHO Anne Winter, PHO Janet Wong, PHO 16
17 Part 2: Overview of 2015/16 Flu Vaccines To provide an overview of: The influenza season and possibilities for the season The publicly-funded influenza vaccines included in the Universal Influenza Immunization Program Issues related to repeat vaccination Objectives PublicHealthOntario.ca 17
18 Outline Background concepts influenza season and implications for season Quadrivalent vaccine Use Why a quadrivalent vaccine? Why the age recommendations? Adjuvanted influenza vaccine Repeat vaccination PublicHealthOntario.ca 18
19 Immunogenicity Immune response to the vaccine May be related to how well it works or how long it lasts, but often don t know for sure Efficacy How well the vaccine works in a clinical trial Preferred method for vaccine authorization Effectiveness How well the vaccine works in real life Determined each year using the test negative casecontrol design Terms PublicHealthOntario.ca 19
20 Sentinel Practitioner Surveillance Network Effectiveness Eligible patients presenting to health care providers with influenza-like symptoms during influenza season are swabbed Influenza Positive Influenza Negative % vaccinated % vaccinated lower higher VE = (1-OR) X 100% PublicHealthOntario.ca 20
21 Season Influenza A/H1N1 Influenza vaccine effectiveness Canada, to seasons Influenza A/H3N2 Influenza B Overall % 57% 55% 60% % 55% 56% 56% * 93% % % 39% 25% 37% % 51% 51% 59% % 41% 68% 50% % - 73% (Yamagata) ** - -8% % PublicHealthOntario.ca * Influenza H1N1 Pandemic ** Mid-season results for A/H3N2 only 21
22 12,000 Total Influenza A and B by Year Ontario, to ,000 8,000 6,000 4,000 Influenza A Influenza B 2, season only includes cases reported up to the end of Week 28 (July 12, 2014) includes cases reported to the end of Week 18 (May 9, 2015) Counts from are underreported and should be interpreted with caution due to modified reporting during the pandemic data do not include approximately 1,200 cases in total for weeks 52, 53 and 1 as they were not reported through iphis. Source: Ontario Ministry of Health and Long-Term Care, integrated Public Health Information System (iphis) database, extracted by Public Health Ontario [2014/07/15] data from the Ontario Respiratory Virus Bulletin; Week 18 (May 3 to 9, Accessed September 13, 2015
23 Influenza Outbreaks, Hospitalizations and Deaths Ontario, ,101 3,698 4, Predominant type / subtype H3N H1N1 and B H3N Outbreaks Hospitalizations Deaths Sources: Week 19 Ontario Respiratory Virus Bulletin (ORVB); and Respiratory Virus Seasonal Summaries; Week 18 ORVB. Notes: Death data may be missing for as some cases were not entered in iphis. 410 hospitalizations not entered in iphis in added to figure shown; Deaths and hospitalizations likely to be underestimates; Changes occurred in reporting practices in that may affect comparisons to prior years
24 Match Poor vaccine effectiveness reflects the fact that the circulating strain and vaccine strain were not well matched Measure match by comparing: Antigenic properties (hemagglutination inhibition test) Genetic sequencing Because of troubles with the hemagglutination inhibition test in , more reliance on genetic sequencing PublicHealthOntario.ca 24
25 Phylogenetic Tree for H3N C.2a Predominant strain A/Switzerland 3C.3a A/Texas 3C.1 Skowronski PublicHealthOntario.ca et al. Eurosurveillance (Accessed September 15, 2015) 25
26 Influenza vaccine composition A/Texas/50/2012(H3N2) A/California/7/2009 (H1N1)pdm09 B/Massachusetts/2/2012 (Yamagata lineage) A/Switzerland/ / 2013(H3N2) A/California/7/2009 (H1N1)pdm09 B/Phuket/3073/2013 (Yamagata lineage) Quadrivalent B/Brisbane/60/2008 (Victoria lineage) PublicHealthOntario.ca Quadrivalent B/Brisbane/60/2008 (Victoria lineage) 26
27 Season Temperate countries in the Southern Hemisphere May 24 September 5, 2015 Australia and New Zealand B and H3N2 (B > H3N2), with small numbers of ph1n1 South Africa H3N2 and ph1n1 with some B South America A > B Chile and Paraguay ph1n1 and H3N2 Argentina H3N2 MMWR September 18, PublicHealthOntario.ca 27
28 Season Viruses tested by CDC from May 24 to Sep 5, viruses tested (58 international, 141 US) 10% ph1n1 - antigenically similar to vaccine strain 59% H3N2 antigenically or genetic group similar to vaccine strain 18% B/Yamagata antigenically similar to vaccine strain 13% B/Victoria antigenically similar to quadrivalent vaccine strain MMWR September 18, PublicHealthOntario.ca 28
29 Season Difference between WHO recommended strain Actual strain used to make the vaccine (egg-adapted, high growth reassortant) which may acquire additional mutations CDC assesses vaccine effectiveness against WHO recommended strains Concern that egg-adapted A/Switzerland strain in the vaccine does not protect well against circulating H3N2 C3.2a viruses based on: ECDC testing using egg-passaged A/Switzerland Low vaccine effectiveness against H3N2 C3.2a viruses preliminarily reported from Australia ECDC Influenza virus characterisation July 2015 PublicHealthOntario.ca 29
30 Implications for Could be any of many possibilities: Mild season H3N2 matched or mismatched season ph1n1 season B season with Yamagata, Victoria or both Any combination of the above Impossible to predict with any accuracy PublicHealthOntario.ca 30
31 Quadrivalent inactivated influenza vaccines
32 Quadrivalent inactivated vaccine Background Contains H3N2 and pandemic H1N1, and 2 influenza B strains B/Victoria lineage B/Yamagata lineage Authorized for the season First year in the publicly-funded program Two products: Fluzone Quadrivalent (Sanofi Pasteur) Fluval Tetra (GlaxoSmithKline) PublicHealthOntario.ca 32
33 Quadrivalent inactivated vaccine Background Similar immunogenicity to trivalent vaccine except greater immune response against the extra B strain However, even for the trivalent vaccine there is some degree of cross-protection across lineages Similar safety profile as the trivalent vaccine Similar use as trivalent vaccine 0.5 ml regardless of age Two doses if 6 months to < 9 years and not previously vaccinated against influenza Safe to use in pregnancy, immunocompromised Safe to use in egg allergic individuals PublicHealthOntario.ca 33
34 PublicHealthOntario.ca Quadrivalent inactivated vaccine Age recommendation NACI recommends quadrivalent vaccine for 6 months to < 18 years Age Ontario s Universal Influenza Immunization Program (UIIP) includes quadrivalent inactivated vaccine for children and adolescents (6 months to < 18 years) Recommended product 6 months to < 2 years Inactivated quadrivalent vaccine 2 to < 6 years Live attenuated quadrivalent vaccine preferred 6 years to < 18 years Inactivated quadrivalent or live attenuated vaccine NACI, Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for , July
35 Why a quadrivalent vaccine?
36 12,000 Total Influenza A and B by Year Ontario to ,000 8,000 6,000 Influenza A Influenza B 4,000 2, season only includes cases reported up to the end of Week 28 (July 12, 2014) includes cases reported to the end of Week 18 (May 9, 2015) Counts from are underreported and should be interpreted with caution due to modified reporting during the pandemic data do not include approximately 1,200 cases in total for weeks 52, 53 and 1 as they were not reported through iphis. Source: Ontario Ministry of Health and Long-Term Care, integrated Public Health Information System (iphis) database, extracted by Public Health Ontario [2014/07/15] data from the Ontario Respiratory Virus Bulletin; Week 18 (May 3 to 9, (Accessed September 13, 2015)
37 Influenza B by Year Ontario, to Doesn't match vaccine Matches vaccine V Y Y V V Y V V V Y Y Y Lineage in vaccine See previous slide for data sources Estimated based on applying distribution of Ontario influenza B strains tested by NML to total laboratory confirmed influenza B strains from iphis 37
38 On average over past seasons: Why a quadrivalent vaccine? ~17 to 25% of influenza cases are B 23% in Ontario over 11 seasons (excluding ) ~40% of the influenza B cases are lineage mismatched ~35% in Ontario over 11 seasons (excluding ) ~10% of influenza cases are lineage mismatched B ~ 8% in Ontario over 11 seasons (excluding ) Ambrose CS. Levin MJ Human Vaccines and Immunotherapeutics 2012: 8(1):81-8 Heikkinen T, et al. Clin Infect Dis 2014; 59: PublicHealthOntario.ca 38
39 Why the quadrivalent influenza vaccine for children?
40 Quadrivalent vaccine for children Higher rates of influenza B in children than adults Study over 10 years of sentinel practitioners in France 0-14 years 15+ years H3N2 49% 51% Pandemic H1N1 60% 40% B 63% 37% Mosnier A, et al. (2015) PLoS ONE 10(9): e doi: /journal.pone May be less cross protection from the trivalent vaccine in children Priming with both lineages may be beneficial for children PublicHealthOntario.ca 40
41 Adjuvanted Influenza Vaccine
42 Fluad (Novartis) Adjuvanted influenza vaccine Authorized in Canada in February 2011, but used in Europe since 1997 MF59 (squalene based, oil-in-water emulsion) Trivalent Authorized for those 65 years of age and over More immunogenic than unadjuvanted vaccine Uncertain whether more effective More local reactions; the same or more systemic reactions; mild and transient NACI Supplemental Statement on MF59 adjuvanted vaccine (Accessed September 15, 2015) PublicHealthOntario.ca 42
43 Adjuvanted influenza vaccine NACI No preferential recommendation Ontario recommendation Primarily available for those 65 years of age and over who live in long term care facilities PublicHealthOntario.ca 43
44 Repeat Vaccination
45 McLean et al McLean HQ et al. Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons. Clinical Infectious Diseases September 29, , 315 encounters of people ( 9 years of age) swabbed for influenza over 8 seasons in Marshfield, Wisconsin; vaccine effectiveness using test negative design 2 analyses of vaccine effectiveness: 1. Vaccination status over two seasons 2. Vaccinated in current season and vaccination history over preceding five seasons PublicHealthOntario.ca 45
46 Analysis 1: Vaccination status over two seasons Compared vaccine effectiveness in those: Vaccinated in both current and previous season Vaccinated in current season only Vaccinated in previous season only Vaccinated in neither season (reference group) Similar vaccine effectiveness across all groups compared to reference group for both influenza A/H3N2 and B PublicHealthOntario.ca 46
47 Analysis 2: Vaccination over preceding five years Compared vaccine effectiveness in those: Vaccinated in current year and 4 or 5 of preceding years (frequent vaccinees) Vaccinated in current year and 1 to 3 of preceding years (infrequent vaccinees) Vaccinated in current season and none of preceding 5 years (non-vaccinees) Not vaccinated in current year or preceding 5 years (reference) PublicHealthOntario.ca 47
48 Vaccination over preceding five years Compared to reference group (not vaccinated in current or preceding 5 years) and after adjusting for several factors, vaccine effectiveness highest in those vaccinated only in the current season Vaccinated in: H3N2 B Only current year and not preceding 5 years (non-vaccinees) 65% (36 80) 75% (50 87) Current and 1 to 3 preceding years (infrequent vaccinees) Current and 4 to 5 preceding years (frequent vaccinees) 35% (13 51) 24% (3 41) 67% (53 77) 48% (29 62) PublicHealthOntario.ca 48
49 Studies inconsistent 17 comparisons found in 10 studies that look at vaccination status over two seasons (including analysis 1 in McLean) Results vary but general order of vaccine effectiveness, highest to lowest: Vaccinated in current season only Vaccinated in both current and previous season Vaccinated in previous season only Vaccinated in neither season (reference group) Recent McLean study found ranking differed by age (Mclean HQ et al JID, May 2015;211: ) PublicHealthOntario.ca 49
50 PublicHealthOntario.ca General conclusions about repeat vaccination Results inconsistent between studies, but generally vaccine effectiveness highest if vaccinated only in current season, but still better to be vaccinated in both seasons than only previous season Uncertain if: A true finding Result of residual confounding in observational studies True finding Immune interference Residual confounding Uncontrolled differences between those repeatedly vaccinated and those who aren t, including past influenza illness exposure Needs further study 50
51 Acknowledgements Dianne Alexander, MOHLTC Dr. Jonathan Gubbay, PHO Emily Karas, PHO Sarah Levitt, MOHLTC Shilpa Raju, formerly PHO Stacy Recalla, MOHLTC Matt Root, PHO Dr. Danuta Skowronski, BCCDC Dr. Doug Sider, PHO Kristen Wheeler, PHO Michael Whelan, PHO Anne Winter, PHO PublicHealthOntario.ca 51
52 Appendix A: Endnotes 2015/16 Publicly Funded Flu Vaccines (TIV) - Slide 10: * Unless specifically requested the TIVs are primarily targeted to adults 18 years of age and older. ^ Egg allergy is not a contraindication to receiving inactivated influenza vaccines (see National Advisory Committee on Immunization Influenza Statement available at /16 Publicly Funded Flu Vaccines (QIV) Slide 11: ^ Egg allergy is not a contraindication to receiving inactivated influenza vaccines (see National Advisory Committee on Immunization Influenza Statement available at 52
Influenza Season: Our Annual Epidemic
2016-2017 Influenza Season: Our Annual Epidemic Kieran Moore AMOH KFLA Piotr Oglaza PHPM Resident KFLA October 2016 Working together for better health Acknowledgements Dr Bryna Warshawsky Public Health
More informationTalkin Flu Mid-America Immunization Coalition August 18, William Atkinson, MD, MPH Immunization Action Coalition
Talkin Flu Mid-America Immunization Coalition August 18, 2016 William Atkinson, MD, MPH Immunization Action Coalition Disclosures William Atkinson has worked as a consultant to Merck and as a speaker for
More informationSummary: Low activity
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2017 2018 53: Dec 28, 2014 Jan 3, 2015 Week 43 (Oct.22 28, 2017) Data extracted Nov.3, 2017 at 11:00 am Summary: Low
More informationSummary: Low activity
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2017 2018 53: Dec 28, 2014 Jan 3, 2015 Week 44 46 (Oct. 29 Nov. 18, 2017) Data extracted Nov. 24, 2017 at 11:00 am
More informationLow Influenza Activity
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2018 2019 53: Dec 28, 2014 Jan 3, 2015 Low Influenza Activity Week 46 (Nov. 11 17, 2018) Data extracted Nov. 23, 2018
More informationInfluenza Update. Lisa Grohskopf, MD, MPH Influenza Division, CDC. NAICP Call 6 October 2015
Influenza Update Lisa Grohskopf, MD, MPH Influenza Division, CDC NAICP Call 6 October 2015 National Center for Immunization and Respiratory Diseases Influenza Division Overview Surveillance update ACIP
More informationDecreasing Activity. Since Sept. 1, 2018: Hospitalizations: 93 ICU* admissions: 16 Deaths: 5. Syndromic in Community Syndromic in Care Syndromic in ED
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2018 2019 53: Dec 28, 2014 Jan 3, 2015 Decreasing Activity Week 52 (Dec. 23 29, 2018) Data extracted Jan. 04, 2019
More informationWeek 43 (Oct , 2016)
Manitoba Health, Seniors and Active Living (MHSAL) Laboratory-confirmed influenza cases this week: Influenza A cases: 3 Influenza B cases: Since Sept. 1, 216: Influenza A cases: 8 Influenza B cases: 1
More informationSummary: Increasing Activity
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2017 2018 53: Dec 28, 2014 Jan 3, 2015 Week 49 (Dec. 03 09, 2017) Data extracted Dec. 15, 2017 at 11:00 am Summary:
More informationSummary: Low and Decreasing Activity
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2017 2018 53: Dec 28, 2014 Jan 3, 2015 Summary: Low and Decreasing Activity Week 16 17 (Apr. 15 28, 2018) Data extracted
More informationSummary: High Activity
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2017 2018 53: Dec 28, 2014 Jan 3, 2015 Week 52 (Dec. 24 30, 2017) Data extracted Jan. 5, 2018 at 11:00 am Summary:
More informationNext report date: May 27 (May 8 21)
Manitoba Health, Healthy Living and Seniors (MHHLS) Influenza Surveillance `Week 215 216 53: Dec 28, 214 Jan 3, 215 Week 17 & 18 (Apr.24 May 7, 216) Data extracted May 13, 216 at 11: am Next report date:
More informationLocal Influenza Surveillance Bulletin Released October 31, 2016
Local Influenza Surveillance Bulletin Released October 31, 2016 Released November 28, 2016 Current Assessment of Influenza Activity in Waterloo Region As of November 28, 2016, there have been 6 laboratory
More informationSummary: Increasing Activity
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2017 2018 53: Dec 28, 2014 Jan 3, 2015 Week 51 (Dec. 17 23, 2017) Data extracted Dec. 29, 2017 at 11:00 am Summary:
More informationSummary: Decreasing. Since Sept. 1, 2017: Hospitalizations: 363 ICU* admissions: 26 Deaths: 32
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2017 2018 53: Dec 28, 2014 Jan 3, 2015 Week 6 (Feb. 4 10, 2018) Data extracted Feb. 16, 2018 at 11:00 am Summary:
More informationSummary: High Activity
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2017 2018 53: Dec 28, 2014 Jan 3, 2015 Week 02 (Jan. 7 13, 2018) Data extracted Jan. 19, 2018 at 11:00 am Summary:
More informationWeek 11 (Mar.13 19, 2016)
Manitoba Health, Healthy Living and Seniors (MHHLS) Influenza Surveillance `Week 215 216 53: Dec 28, 214 Jan 3, 215 Week 11 (Mar.13 19, 216) Data extracted Mar. 24, 216 at 11: am Laboratory-confirmed influenza
More informationWhat's New With The Flu. Claire Farella RN BScN MN Manager Community Health Protection
What's New With The Flu Claire Farella RN BScN MN Manager Community Health Protection Historical Data 100 anniversary of the Spanish Flu - H1N1 500 million infected world wide with 50-100 million deaths-
More informationLow Influenza Activity
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2018 2019 53: Dec 28, 2014 Jan 3, 2015 Low Influenza Activity Week 45 (Nov. 4 10, 2018) Data extracted Nov. 16, 2018
More informationSummary: Sustained Influenza B Activity
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2017 2018 53: Dec 28, 2014 Jan 3, 2015 Summary: Sustained Influenza B Activity Week 9 (Feb. 25 Mar. 3, 2018) Data
More informationInfluenza vaccine Revisiting Old and Addressing Current Issues. Dr. Leilani T. Sanchez, DPPS, DPIDSP Manila, 18 February 2016
Influenza vaccine Revisiting Old and Addressing Current Issues Dr. Leilani T. Sanchez, DPPS, DPIDSP Manila, 18 February 2016 QIV QIV 2 Influenza Leilani Sanchez, MD 18 Feb 2016 PIDSP Annual Convention
More informationLow Influenza Activity
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2018 2019 53: Dec 28, 2014 Jan 3, 2015 Low Influenza Activity Week 40 41 (Sept. 30 Oct. 13, 2018) Data extracted Oct.
More informationHigh Activity. Since Sept. 1, 2018: Hospitalizations: 62 ICU* admissions: 8 Deaths: <5. Syndromic in Community Syndromic in Care Syndromic in ED
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2018 2019 53: Dec 28, 2014 Jan 3, 2015 High Activity Week 51 (Dec.16 22, 2018) Data extracted Dec. 28, 2018 at 11:00
More informationAn Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for
An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2013-2014 Preamble The National Advisory Committee on Immunization (NACI)
More informationNo Laboratory-confirmed Influenza Activity
Manitoba Health, Seniors and Active Living (MHSAL) Influenza Surveillance Report `Week 2018 2019 53: Dec 28, 2014 Jan 3, 2015 No Laboratory-confirmed Influenza Activity Week 38 39 (Sep. 16 29, 2018) Data
More informationManitoba Health, Healthy Living and Seniors (MHHLS) Week 9 (Feb.28 Mar.5, 2016) == Severe outcomes associated with. == Cases and cumulative incidence
Manitoba Health, Healthy Living and Seniors (MHHLS) Influenza Surveillance `Week 215 216 53: Dec 28, 214 Jan 3, 215 Week 9 (Feb.28 Mar.5, 216) Data extracted Mar. 11, 216 at 11: am Laboratory-confirmed
More informationOntario Public Drug Programs, Ministry of Health and Long-Term Care. For the Influenza Immunization Season
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Notice from the Executive Officer: Pharmacist Administration of Publicly Funded Influenza Vaccines and Claims Submission using the Health
More informationAlberta Health. Seasonal Influenza in Alberta Season. Analytics and Performance Reporting Branch
Alberta Health Seasonal Influenza in Alberta 2015-2016 Season Analytics and Performance Reporting Branch August 2016 For more information contact: Analytics and Performance Reporting Branch Health Standards,
More informationWeek 11: March 11 to March 17, 2018
2017/18 Season Week in Review: Week 11: March 11 to March 17, 2018 Influenza Activity Indicator Assessment of Indicator* Interpretation Reported cases Percent Positive of Flu Specimens Local Institutional
More informationWeek 15: April 8 to April 14, 2018
2017/18 Season Week in Review: Week 15: April 8 to April 14, 2018 Influenza Activity Indicator Assessment of Indicator* Interpretation Reported cases Percent Positive of Flu Specimens Local Institutional
More informationMA Adult Immunization Coaltion Flu Update September 28, 2016
MA Adult Immunization Coaltion Flu Update September 28, 2016 Susan M. Lett, MD, MPH Medical Director, Immunization Program Division of Epidemiology and Immunization Massachusetts Department of Public Health
More informationKey facts about influenza vaccine
Key facts about influenza vaccine Dr Wan Noraini Wan Mohamed Noor Head of Surveillance Sector Disease Control Division, MOH Malaysia 4 May 2018 drwnoraini@moh.gov.my The Outline: Introduction: Influenza
More information* Rates were not calculated due to small numbers.
Manitoba Health, Healthy Living and Seniors (MHHLS) Influenza Surveillance `Week 215 216 53: Dec 28, 214 Jan 3, 215 Week 48 (Nov.29 Dec.5, 215) Data extracted Dec.11, 215 at 11: am Laboratory-confirmed
More informationInfluenza Prevention Update
Influenza Prevention Update Dean A. Blumberg, MD, FAAP Disclosure speakers bureau: sanofi pasteur, Merck Discussion off label use of FDA approved vaccines Influenza Prevention Update Seasonal influenza
More informationSEASONAL INFLUENZA VACCINE INFORMATION FOR IMMUNIZATION PROVIDERS
2015-2016 SEASONAL INFLUENZA VACCINE INFORMATION FOR IMMUNIZATION PROVIDERS Office of the Chief Medical Officer of Health Communicable Disease Control Branch Immunization Program August 2015 Table of Contents
More informationQ&A: Publicly Funded Seasonal Inactivated Influenza Vaccine Information for
Q&A: Publicly Funded Seasonal Inactivated Influenza Vaccine Information for 2018-2019 -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
More informationONTARIO RESPIRATORY PATHOGEN BULLETIN. Assessment of Influenza Activity in Ontario
ONTARIO RESPIRATORY PATHOGEN BULLETIN Surveillance Week 49: (December 2, 2018 - December 8, 2018) This issue of the Ontario Respiratory Pathogen Bulletin provides information on the surveillance period
More informationUpdate on influenza monitoring and vaccine development
Update on influenza monitoring and vaccine development Annette Fox WHO Collaborating Centre for Reference and Research on Influenza at The Peter Doherty Institute for Infection and Immunity 1 Outline Why
More informationFor the 2017/2018 Influenza Immunization Season. Patient Eligibility. Description. Ontario Public Drug Programs, Ministry of Health and Long-Term Care
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Notice from the Executive Officer: Pharmacist Administration of Publicly Funded Influenza Vaccines and Claims Submission using the Health
More informationInfluenza Global Epidemiologic Update
Influenza Global Epidemiologic Update November 10 th, 2017 1. GLOBAL WHO SUMMARY based on data up to 15 October 2017 North America: Overall influenza virus activity remained low, with detections of predominantly
More informationCurrent Assessment of Influenza Activity in Waterloo Region. Influenza Activity: August 28, 2016 to October 22, 2016 (Weeks 35 to 42)
Region of Waterloo Public Health and Emergency Services Local Influenza Surveillance Bulletin Released October 31, 2016 Current Assessment of Influenza Activity in Waterloo Region As of October 31, 2016,
More informationUpdate on Influenza Vaccines, the Influenza Season, and the Impact of Vaccination on Influenza Disease Burden
National Center for Immunization & Respiratory Diseases Update on Influenza Vaccines, the 2017 2018 Influenza Season, and the Impact of Vaccination on Influenza Disease Burden Melissa Rolfes, PhD MPH Epidemiologist
More informationGlobal Influenza Virus Surveillance and WHO Influenza Vaccine Virus Recommendations for the Northern Hemisphere Influenza Season
Global Influenza Virus Surveillance and WHO Influenza Vaccine Virus Recommendations for the Northern Hemisphere 2015-16 Influenza Season Jacqueline Katz, Ph. D. Deputy Director (acting), Influenza Division
More informationQuestions and Answers
Questions and Answers Recommended composition of influenza virus vaccines for use in the southern hemisphere 2016 influenza season and development of candidate vaccine viruses for pandemic preparedness
More informationInfluenza Activity in Indiana
Objectives of Influenza Surveillance Influenza Activity in Indiana 2014-2015 Reema Patel, MPH Respiratory Epidemiologist Epidemiology Resource Center Indiana State Department of Health Monitor influenza-like
More informationInfluenza: Wrap- Up and Preview of the Upcoming Season. October 6, 2016 Anita Valiani, MPH
Influenza: 2015-2016 Wrap- Up and Preview of the Upcoming Season October 6, 2016 Anita Valiani, MPH Anita.valiani@dhhs.nc.gov NC SHARPPS Surveillance for Healthcare-Associated Infections and Resistant
More informationONTARIO RESPIRATORY PATHOGEN BULLETIN. Assessment of Influenza Activity in Ontario
ONTARIO RESPIRATORY PATHOGEN BULLETIN Surveillance Week 1: (December 30, 2018 - January 5, 2019) This issue of the Ontario Respiratory Pathogen Bulletin provides information on the surveillance period
More informationInfluenza immunization timing
Influenza immunization timing Technical report March 2017 Public Health Ontario Public Health Ontario is a Crown corporation dedicated to protecting and promoting the health of all Ontarians and reducing
More informationInfluenza Clinical Bulletin # 3: October 8, 2009 Vaccination Guidelines for Patients for Influenza
The purpose of this document is to provide NYP providers with the most current recommendations regarding influenza vaccination for their patients. It is important to recognize that guidance reflects optimal
More informationInfluenza Surveillance in Ireland Weekly Report Influenza Week (1 st 7 th October 2018)
Influenza Surveillance in Ireland Weekly Report Influenza Week 40 2018 (1 st 7 th October 2018) Summary This is the first influenza surveillance report of the 2018/2019 influenza season. All indicators
More informationCCDR STATEMENT ON SEASONAL INFLUENZA VACCINE FOR Preamble
CANADA COMMUNICABLE DISEASE REPORT CCDR AUGUST 2012 VOLUME 38 ACS-2 ISSN 1481-8531 https://doi.org/10.14745/ccdr.v38i00a02 An Advisory Committee Statement (ACS) National Advisory Committee on Immunization
More informationNovember 5 to 11, 2017 (Week 45)
Hanks you Overall Summary November 5 to 11, 2017 (Week 45) Influenza activity crossed the seasonal threshold in week 45, indicating the beginning of the influenza season at the national level. The number
More informationAlberta Health. Seasonal Influenza in Alberta. 2016/2017 Season. Analytics and Performance Reporting Branch
Alberta Health Seasonal Influenza in Alberta 2016/2017 Season Analytics and Performance Reporting Branch September 2017 For more information contact: Analytics and Performance Reporting Branch Health Standards,
More information1 STATEMENT ON SEASONAL INFLUENZA VACCINE FOR
1 STATEMENT ON SEASONAL INFLUENZA VACCINE FOR 2015-2016 An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) Canadian Immunization Guide Chapter on Influenza and Statement
More informationMDPH Influenza Update
Massachusetts Department of Public Health Bureau of Infectious Disease and Laboratory Sciences MDPH Influenza Update 9-27-2017 Susan M. Lett, MD, MPH Medical Director, Immunization Program MA Department
More informationManitoba Influenza Surveillance Report
Manitoba Influenza Surveillance Report 212/213 Season Summary: Week 47: Nov 18-24, 212 The influenza-like-illness rate was 4.8% with 5% of sentinel physician sites reporting. There was one case of influenza
More informationQuestions and Answers for Health Care Worker (HCW) Influenza Immunization Coverage Reporting by Ontario Hospitals and Long-Term Care Homes (LTCHs)
Questions and Answers for Health Care Worker (HCW) Influenza Immunization Coverage Reporting by Ontario Hospitals and Long-Term Care Homes (LTCHs) Part 1: Reporting for the 2016-2017 season 1. Are HCW
More informationONTARIO RESPIRATORY PATHOGEN BULLETIN. Assessment of Influenza Activity in Ontario
ONTARIO RESPIRATORY PATHOGEN BULLETIN Surveillance Week 44: (October 28, 2018 - November 3, 2018) This issue of the Ontario Respiratory Pathogen Bulletin provides information on the surveillance period
More informationDecember 3 to 9, 2017 (Week 49)
Hanks you December 3 to 9, 2017 (Week 49) Overall Summary Overall, Influenza activity continues to increase across Canada; however many indicators such as hospitalizations, outbreaks and geographic spread
More informationAn Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2016-2017 1 PREAMBLE
More informationBritish Columbia Influenza Surveillance Bulletin Influenza Season , Number 23, Weeks August 13 to September 23, 2017
British Columbia Influenza Surveillance Bulletin Influenza Season 216-17, Number 23, Weeks 33-38 August 13 to September 23, 217 Table of Contents: British Columbia: Sentinel Physicians Page 2 Children
More informationSummary. Week 11/2017 (13 19 March 2017) Season overview
Summary Week 11/2017 (13 19 March 2017) Influenza activity across the region continued to decrease with the great majority of countries reporting low intensity. The proportion of influenza virus detections
More informationQuadrivalent Flu Vaccines: Four Means More Protection
Quadrivalent Flu Vaccines: Four Means More Protection By Keith Berman, MPH, MBA, and Luke Noll AHEAD OF EACH flu season, experts at the U.S. Food and Drug Administration (FDA) and the World Health Organization
More informationAnnual Influenza Review
Annual Influenza Review 2017-2018 A review of past flu trends and what to expect in the coming season. Count on Our Support, Educational Resources and Products to Help You Prepare for the Next Influenza
More informationStable, Above Historical Average Influenza Activity due to Novel Pandemic H1N1 in BC
BRITISH COLUMBIA (BC) INFLUENZA SURVEILLANCE 8-9 BULLETIN Vanita Sahni, Travis Hottes, Naveed Janjua, & Danuta Skowronski Number 29: Week 33 BCCDC Influenza & Emerging Respiratory Pathogens Team August
More informationBritish Columbia Influenza Surveillance Bulletin
British Columbia Influenza Surveillance Bulletin Influenza Season 2016-17, Number 22, Weeks 18-32 April 30 to August 12, 2017 Table of Contents: British Columbia: Sentinel Physicians Page 2 Children s
More informationSurveillance Overview
Number of Positive Specimens Percent Positive Number of Positive Specimens National Center for Immunization & Respiratory Diseases 2016-17 Surveillance Overview Lynnette Brammer, MPH Epidemiologist, Influenza
More informationImmunization Update Tamara Sheffield, MD, MPA, MPH
Immunization Update 2015 Tamara Sheffield, MD, MPA, MPH Disclosure I do not have any relevant financial relationships with any commercial interests I am a Medical Director employed by Intermountain Healthcare
More informationInfluenza: A recap of the season
Influenza: A recap of the 2012 2013 season March 22, 2013 Debra Blog MD, MPH Director Division of Epidemiology What are we going to talk about The 2012 13 Influenza Vaccine Influenza Activity and Surveillance
More informationImmunization with Influenza Vaccine (Inf)
Immunization with Influenza Vaccine (Inf) Background Influenza is a respiratory infection caused by either the type A or type B influenza viruses, and occurs in populations worldwide. Although it is generally
More informationDeveloped by the Healthcare Worker Immunization Strategy Committee
Developed by the Healthcare Worker Immunization Strategy Committee What is Influenza? Influenza acute respiratory illness with fever (>38 C) and cough and one or more of the following: Muscle aches, headache,
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXXIII NUMBER 4 September 2018 CONTAGIOUS COMMENTS Department of Epidemiology Influenza Vaccination Suchitra Rao, MBBS and Jason Child, PharmD New influenza vaccines have arrived. It is important
More informationAdult Immunization Update 2015
Adult Immunization Update 2015 Objectives Upon completion of this session, the pharmacist should be able to: Compare and contrast previous versions of the ACIP immunization schedules with the most recent
More informationHemagglutinin Neuraminidase
Evolving Vaccine Guidance: Influenza, Meningococcal & HPV Vaccines H. Cody Meissner, M.D. Professor of Pediatrics Tufts University School of Medicine Maine Chapter AAP Bar Harbor, Maine October 16, 2016
More informationH1N Influenza Q & A With a Focus on Panvax
November 6, 2009 1 of 5 H1N1-2009 Influenza Q & A With a Focus on Panvax 1. What H1N1 vaccines are available in Canada? The vaccines available in Canada to protect against H1N1-2009 influenza are: Arepanrix
More informationMEMORANDUM. RE: Ontario Influenza and Respiratory Infection Surveillance Program
1 MEMORANDUM TO: Medical Officers of Health and Associate Medical Officers of Health Directors of Communicable Disease and Vaccine Preventable Disease Control Communicable Disease Managers RE: Ontario
More informationHELP PREVENT THE FLU WITH FLUMIST QUADRIVALENT
HELP PREVENT THE FLU WITH FLUMIST QUADRIVALENT THE NEEDLE-FREE INTRANASAL QUADRIVALENT FLU VACCINE Inf luenza Vaccine Live, Attenuated, Intranasal TABLE OF CONTENTS 2 What is FluMist Quadrivalent? 3 How
More informationTo view an archived recording of this presentation please click the following link:
To view an archived recording of this presentation please click the following link: http://pho.adobeconnect.com/pipr4mxgx1rb/ Please scroll down this file to view a copy of the slides from the session.
More information1 INFLUENZA IMMUNIZATION IN YORK REGION: RATES OF UPTAKE AMONG HEALTH CARE WORKERS IN HOSPITALS AND LONG-TERM CARE HOMES
1 INFLUENZA IMMUNIZATION IN YORK REGION: RATES OF UPTAKE AMONG HEALTH CARE WORKERS IN HOSPITALS AND LONG-TERM CARE HOMES The Health and Emergency Medical Services Committee recommends the adoption of the
More informationInfluenza Surveillance in Ireland Weekly Report Influenza Week (12 th 18 th November 2018)
Influenza Surveillance in Ireland Weekly Report Influenza Week 46 2018 (12 th 18 th November 2018) Summary All indicators of influenza activity in Ireland were at low levels during week 46 2018 (week ending
More informationManitoba Influenza Surveillance Report
Manitoba Influenza Surveillance Report 2012/2013 Season Week 14 Mar 31 Apr 6, 2013 Mar 31 - Apr 6: The proportion of patients visiting sentinel physicians for influenza-likeillness was 11% (up from 0%
More informationInfluenza and Respiratory Infection Surveillance Summary Report: Season
Influenza and Respiratory Infection Surveillance Summary Report: 2012 13 Season SURVEILLANCE REPORT March 2015 Public Health Ontario Public Health Ontario is a Crown corporation dedicated to protecting
More informationManitoba Influenza Surveillance Report 2012/2013 Season
Week 11 Mar 10-16, 2013 Manitoba Influenza Surveillance Report 2012/2013 Season Mar 10-16: The proportion of patients visiting sentinel physicians for influenza-likeillness was 2.5% (down from 7.8% last
More informationInfluenza Weekly Surveillance Bulletin
Influenza Weekly Surveillance Bulletin Northern Ireland, Week 16 (18 April 216 24 April 216) Summary In Northern Ireland, as of week 16 216, the 215/16 influenza season has seen low community influenza
More informationDisclosures. No support One off-label recommendation
Seasonal Influenza John B. Murphy, MD Professor of Medicine and Family Medicine Warren Alpert Medical School of Brown University Executive Vice President for Physician Affairs, Lifespan 8/21/14 Disclosures
More informationUpdated: 26 August 2010
Australian Technical Advisory Group on Immunisation (ATAGI) Updated advice on the use of pandemic and seasonal influenza vaccines in children
More informationRespiratory Outbreak Update,
Respiratory Outbreak Update, 2016-17 Annual Toronto Fall LTC IPAC Education Day Nov 2, 2016 Dr. Irene Armstrong Associate Medical Officer of Health iarmstr@toronto.ca 416-338-7993 Objectives Review 2015-16
More informationADDENDUM LAIV Use in Children and Adolescents Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
ADDENDUM TO THE STATEMENT ON SEASONAL INFLUENZA VACCINE FOR 2016-2017 ADDENDUM LAIV Use in Children and Adolescents Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
More informationINFLUENZA Surveillance Report Influenza Season
Health and Wellness INFLUENZA Surveillance Report 2011 2012 Influenza Season Population Health Assessment and Surveillance Table of Contents Introduction... 3 Methods... 3 Influenza Cases and Outbreaks...
More informationANNUAL INFLUENZA REPORT,
Manitoba Health, Healthy Living and Seniors ANNUAL INFLUENZA REPORT, 214 215 July 1, 214 June 3, 215 Epidemiology & Surveillance Public Health Branch Public Health and Primary Health Care Division December,
More informationInfluenza and the Flu Shot Facts for Health Care Workers
Influenza and the Flu Shot Facts for Health Care Workers 2014-2015 Presentation to (group name) Your Name Your Title Date Influenza Facts o Highly contagious and common respiratory illness caused by influenza
More informationGIHSN-China s experience & Results of season Beijing, China
GIHSN-China s experience & Results of season 2015-2016 Beijing, China 1. Chinese Center for Disease Control and Prevention 2.WHO Collaborating Centre for Infectious Disease Control and Epidemiology, School
More informationAlberta Respiratory Virus Surveillance Report Update for Flu Weeks 31-34: (Jul 28 Aug 24, 2013)
Weekly Update August 2, 13 The purpose of this report is to inform Public Health staff, primary providers, acute staff and other community practitioners about recent and historical respiratory virus activity
More informationSummary. Week 13/2018 (26 31 March 2018) season overview
Summary Week 13/2018 (26 31 March 2018) Influenza viruses continued to circulate in the Region, while all countries reported low or medium intensity of activity of respiratory infections. Influenza continued
More informationVaccine Safety Monitoring for ph1n pandemic vaccine:
Vaccine Safety Monitoring for ph1n1 2009 pandemic vaccine: lessons learned in British Columbia 2011: Eighth Annual Bi-National Cross Border Workshop Pacific Northwest Border Health Alliance Monika Naus
More informationSummary. Week 15/2018 (9 15 April 2018) season overview
Summary Week 15/2018 (9 15 April 2018) Influenza viruses continued to circulate in the Region with 26% of the individuals sampled from primary healthcare settings testing positive, while all countries
More informationFlu Vaccine Access Via Pharmacy Vaccine Network
Re: Flu Vaccine Access Via Pharmacy Vaccine Network Effective 9/15/2016, IEHP Medi-Cal and Medicare DualChoice Cal MediConnect (IEHP Direct) Members who are over 18 years old may obtain Flu Vaccines through
More informationAlberta Respiratory Virus Surveillance Report Update for Flu Week 5 (Jan 26 Feb 1, 2014)
Update for (Jan 26 Feb 1, 14) Weekly Update February 4, 14 The purpose of this report is to inform Public Health staff, primary care providers, acute care staff and other community practitioners about
More informationSARI, Influenza and Respiratory Pathogens
ISSN 2324-3589 Hospital Surveillance SARI, Influenza and Respiratory Pathogens Monthly Report, November 15 SUMMARY During weeks 45-48 (2 November 29 November 15), influenza activity decreased in hospital
More information